•
Jun 30, 2013

ResMed Q4 2013 Earnings Report

Total Revenue
$415M
Previous year: $1.37B
-69.7%
EPS
$0.62
Previous year: $0.53
+17.0%
Gross Profit
$260M
Previous year: $226M
+14.7%
Cash and Equivalents
$876M
Previous year: $810M
+8.2%
Free Cash Flow
$108M
Previous year: $84.9M
+27.1%
Total Assets
$2.21B
Previous year: $2.14B
+3.4%

ResMed

ResMed